File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Conference Paper: Efficacy and Safety of Single Agent Sunitinib in Treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: A Prospective, Open-label, Phase II Study

TitleEfficacy and Safety of Single Agent Sunitinib in Treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: A Prospective, Open-label, Phase II Study
Authors
Issue Date2013
PublisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487
Citation
The 4th Asia-Pacific Primary Liver Cancer Expert Meeting, Busan, Korea, 5-7 July 2013. In Liver Cancer, 2013, v. 2 n. 3-4, p. 275 How to Cite?
DescriptionConference Theme: A Bridge to a Consensus on HCC Management
Postal oral session: PO-32
Persistent Identifierhttp://hdl.handle.net/10722/186804
ISSN

 

DC FieldValueLanguage
dc.contributor.authorYau, TCCen_US
dc.contributor.authorLeung, RCYen_US
dc.contributor.authorWong, HYHen_US
dc.contributor.authorChiu, JWYen_US
dc.contributor.authorChan, Pen_US
dc.contributor.authorTang, YFen_US
dc.contributor.authorCheung, TTen_US
dc.contributor.authorPang, RWCen_US
dc.contributor.authorFan, STen_US
dc.contributor.authorPoon, RTPen_US
dc.date.accessioned2013-08-20T12:21:03Z-
dc.date.available2013-08-20T12:21:03Z-
dc.date.issued2013en_US
dc.identifier.citationThe 4th Asia-Pacific Primary Liver Cancer Expert Meeting, Busan, Korea, 5-7 July 2013. In Liver Cancer, 2013, v. 2 n. 3-4, p. 275en_US
dc.identifier.issn2235-1795-
dc.identifier.urihttp://hdl.handle.net/10722/186804-
dc.descriptionConference Theme: A Bridge to a Consensus on HCC Management-
dc.descriptionPostal oral session: PO-32-
dc.languageengen_US
dc.publisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487-
dc.relation.ispartofLiver Canceren_US
dc.rightsLiver Cancer. Copyright © S. Karger AG.-
dc.titleEfficacy and Safety of Single Agent Sunitinib in Treating Sorafenib Refractory Advanced Hepatocellular Carcinoma Patients: A Prospective, Open-label, Phase II Studyen_US
dc.typeConference_Paperen_US
dc.identifier.emailYau, TCC: tyaucc@hku.hken_US
dc.identifier.emailWong, HYH: h9904815@graduate.com.hken_US
dc.identifier.emailTang, YF: vyftang@hku.hken_US
dc.identifier.emailCheung, TT: cheung68@hku.hken_US
dc.identifier.emailPang, RWC: robertap@hku.hken_US
dc.identifier.emailFan, ST: stfan@hku.hken_US
dc.identifier.emailPoon, RTP: poontp@hku.hken_US
dc.identifier.authorityYau, TCC=rp01466en_US
dc.identifier.authorityPang, RWC=rp00274en_US
dc.identifier.authorityFan, ST=rp00355en_US
dc.identifier.authorityPoon, RTP=rp00446en_US
dc.identifier.doi10.1159/000343846-
dc.identifier.hkuros217126en_US
dc.identifier.volume2-
dc.identifier.issue3-4-
dc.identifier.spage275-
dc.identifier.epage275-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats